GBI was invited by Bloomberg to co-host a webinar held on July 16, 2020, discussing the current market landscape in China for the development of programmed death-1/programmed death-ligand 1 (PD-1/L1) therapies, as well as latest trends in COVID-19 vaccines development. GBI’s head of content Robert McTiernan presented “China Emerges as a PD-1/L1 Powerhouse: Key players…